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Abstract 
 
Arsha (Piles) is the one of the most common disease encountered in clinical and surgical 
practice. Arsha incidence increases with advancing age, at least 50% of people over the age of 
50 years have some degree of haemorrhoidal symptoms.  In this study an attempt has been 
made to treat the “disease” with Chirabilwadi quatha (Panartha) and Kaseesadi thaila 
(Sthanika abhyanga). Total thirty patients were selected by simple randomized method and 
allocated into three groups called Group A, B, C. Each group had ten patients. Group A. treated 
with Chirabilwadi quatha (Panartha), Group B. treated with Kaseesadi thaila and Group C. 
treated with combination of Chirabilwadi quatha and Kaseesadi thaila. Total study period was 
nighty days in that thirty days was treatment and sixty days was follow-up. The effect of 
treatment was observed both in subjective symptoms and objective parameters. Non-
significant, Significant and highly significant results were observed in subjective parameters, 
objective parameters and overall in all three groups. 
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Introduction 
Arsha is a kind of disease which is 
most unkind towards mankind. By looking 
into the history one can understand that 
great saints like adishankara who revived 
the vedic literature, and famous rulers like 
Napoleon suffered from this disease (1). 
Arsha incidence increases with advancing 
age, at least 50% of people over the age of 
50 years have some degree of 
haemorrhoidal symptoms (2).  Now a day 
every person suffered from any one of the 
complaint of piles during their life time. 
Causes may be due to portal hypertension, 
hereditary or congenital, constipation, 
prostatic enlargement, pregnancies, long 
standing postures, insufficient dietic fiber 
(3).  etc… As per Sushruta the doshas by 
their aggravating causes, dislodges from 
their normal seats alone or combined with 
other including the rakta, reaches the 
maladwara (marga) and causes the 
vitiation of gudavalis resulting the 
production of mamsankuras especially in 
mandagni persons ( 4 ). In this present era 
more number of patients are interested or 
inclined to take oral medicines rather than 
surgical procedures because they knew that 
surgical procedures may give raise one or 
other complications (5). Hence, aimed to 
study the first line of treatment of Sushrutha 
which is known as oushadha chikitsa ( 4 ). 
Good results of initial clinical trials of 
chirabilwadi quatha ( 6,8 ) as panartha and 
kaseesadi thaila (7,8) as sthanika abhyanga  
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inspired me to take up the present work. 
“The medical management of arsha with 
chirabilwadi quatha and kaseesadi thaila 
sthanika abhyanga”. 
 
Aim: 
1. This study was conducted to evaluate 
the efficacy and safety of Chirabilwadi 
quatha and Kaseesadi thaila in Arsha. 
 
Objectives 
1. Primary efficacy objective - Study of 
the effect of Chirabilwadi quatha and 
Kaseesadi thaila on changes in 
parameters - pain, bleeding, nature of 
stool, pressure on defecation, pruritus 
ani, mucous discharge, number of 
external and internal pile mass, size, 
character, tenderness on pressure, 
movement, from Baseline to after 
treatment in Arsha (Piles). 
2. Secondary efficacy objective – Study 
of the effect of Chirabilwadi quatha 
and Kaseesadi thaila on changes in 
parameters - pain, bleeding, nature of 
stool, pressure on defecation, pruritus 
ani, mucous discharge, number of 
external and internal pile mass, size, 
character, tenderness on pressure, 
movement, from Baseline to after 
Follow up in Arsha (Piles). 
3. Exploratory efficacy objective – Study 
of the effect of Chirabilwadi quatha 
and Kaseesadi thaila on changes in 
parameters - pain, bleeding, nature of 
stool, pressure on defecation, pruritus 
ani, mucous discharge, number of 
external and internal pile mass, size, 
character, tenderness on pressure, 
movement, from Baseline to After 
treatment (30 days, After Follow up 
(90 days) in Arsha (Piles). 
4. Safety objective – Evaluation of the 
safety of Chirabilwadi quatha and 
Kaseesadi thaila  in term of the 
occurrence of adverse events, changes 
from baseline in vital signs (B.P. Heart 
and Respiratory rate) and safety 
laboratory results (Bio-chemistry, 
Hematology ) in Arsha (Piles) patients.  
 
Hypothesis 
Recent statistics reveals that 
irrespective of age, sex, socio – economic 
status, people suffer from piles. Now a day 
every person suffered from any one of the 
complaint of piles during their life time. 
Arsha incidence increases with advancing 
age, at least 50% of people over the age of 
50 years have some degree of 
haemorrhoidal symptoms. The food habits 
and life styles of modern man also added to 
the increase in rate of incidence of Arshas. 
Piles pierce through may appear as a simple 
haemorrhoidal masses that descending. 
1. Component of Hypothesis which to be 
total tested - Is there any presence of a 
positive effect relationship on the 
Arsha (Piles) patients who taken 
Chirabilwadi quatha and Kaseesadi 
thaila. 
2. Component could not be tested - 
Assessment of the G.I.Tract, kidney 
and liver parameters because 
Chirabilwadi quatha and Kaseesadi 
thaila   is helpful in the long term use. 
3. Comments over hypothesis testing - 
Symptoms like pain, bleeding, Nature 
of stool, pressure on defecation, 
pruritus ani, mucous discharge and 
other studied but more importance 
given to  pain  of Arsha (Piles). As it 
interferes the day to day activities. 
That’s why more emphasis is given on 
symptomatic relief. Before treatment, 
After treatment and After Follow-up is 
to be tested so that one may observe 
deterioration, stable, improvement and 
marked respond. 
4. This Hypothesis was subjected to 
testing by using open trial clinical 
study. 
5. This proposed operative Hypothesis 
for the present study is derived on the 
basis of 
     A. The description in the classical 
Ayurvedic texts. 
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      B. The clinical experiences of 
doctors in contemporary medicine and as 
well as in  classics. 
      C. The survey of the literature 
regarding contemporary research on Arsha 
(Piles).          
 
Materials: 
Following were the materials taken 
for the clinical study. 
 
Drugs: 
1. Chirabilwadi Quatha 
2. Kaseesadi thaila 
 
Instruments: 
1. Proctoscopy (Lighted) 
2. Lithotomy Table 
3. Stainless steel spoon (modified) 
4. Hand gloves 
5. Cotton ball  
 
Methods: 
Study design 
The study was an open clinical trial 
conducted in Dr. B.N.M.E.T’s Shri 
Mallikarjun Swamji’s Post Graduate and 
Research Center, Bijapur. A total number 
of thirty patients were selected incidentally 
on the basis of inclusion criteria. The 
patients thus selected were randomly 
allocated to Three groups assigned as A, B 
and C were treated with chirabiwadi 
quatha, kaseesadi thaila and chirabilwadi 
quatha followed by kaseesadi thaila 
respectively. 
 
GROUP – A. = In this group the patients 
were administered 10ml of chirabilwadi 
quatha with sukhoshna jala, paschat 
bhakta, prathaha and ratrikala for 1 masa 
followed by takra as pathya. 
GROUP – B. = In this group the patients 
were get sthanika abhyanga on Arsha with 
kaseesadi taila, santulita matra, paschat 
malapravruthi for 1 masa followed by 
takra as pathya. 
 
GROUP – C. = In this group the patients 
were followed group – A and group – B as 
a combined. 
The patients were advised to attain the 
O.P.D. for periodic follow-up. They were 
also advised to consult immediately, if any 
discomfort is felt in the course of follow-up 
period. Total 90 days trial period in that 30 
days treatment and 60 days follow up 
period. Data is recorded before treatment, 
after treatment and after follow up on 
subjective and objective criteria and 
entered in a special clinical proforma which 
was prepared with relevance to the 
Ayurvedic and Allied science. A written 
informed consent was obtained from all 
patients.  
Sample size - A total of thirty patients were 
selected incidentally on the basis of 
prevalence of Arsha (Piles) quoted in the 
text one can calculate the minimum 
required sample size for the study by using 
marginal error or standard error. The 
patients thus selected were randomly 
allocated to three groups. 
 
Inclusion Criteria 
1. Arsha diagnosed according to classical 
and modern signs and symptoms and 
on examinations. 
2. Patients were selected irrespective of 
sex, religion and place. 
3. Patients were selected in between 20 to 
50 years age group and of any degree 
any type of Arshas. 
 
Exclusion Criteria 
1. Age below 20 years and above 50 
years. 
2. Associated with fistula and polyp. 
3. Carcinoma of rectum, prolapsed 
rectum, congenital abnormalities of 
anus. 
4. Gangrene, Fibrosis Suppuration of 
piles. 
5. Any systemic disorders as Anaemia 
etc.    
6. Debilitating disorders as Tuberculosis, 
Rheumatoid arthritis, oncology etc. 
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Pilot Study 
A pilot study on 6 patients was 
done, in order to grade the severity for 
individual symptom and over all severity 
dose fixation, determine end point and 
grading for the assessment of clinical 
improvement. 
 
Investigations 
Hb% , R.B.S., Urine routine etc (If 
found necessary) 
 
Assessment of Variables 
Clinical assessment was made for the 
severity of the disease and for the clinical 
improvement. 
Grading for the severity of individual 
subjective and objective parameters, 
assessment and as well as for overall 
assessment was framed as four point scale 
(1-4). The gradings of 12 variables is given 
along with clinical proforma especially 
designed for the study on Arsha. 
The severity of each variable ranging 
from Normal – 1, Mild – 2, Moderate – 3, 
Severe – 4. 
 
Overall Assessment of Severity 
Before treatment (Starting day), 
After treatment (after 30 days), After 
follow-up (after 90 days). Based on the 
scoring of variables, overall severity was 
graded as  
Prakrita (Normal): 1 to 12, Mrudu (Mild): 
13 to 24, Madyama (Moderate): 25 to 36 
and Teevra (Severe): 37 to 48.   
 
Assessment of Clinical Improvement 
Clinical improvement of the disease 
was based on improvement in the clinical 
findings and reduction in the severity of the 
symptoms and overall severity of the 
disease. Grading for the clinical 
improvement individual symptoms and 
over all severity is as enumerated below. 
 
 
 
Grading For the Clinical Improvement 
For Individual Variable 
C.D. –    Clinically deteriorated,   i.e. 
increase in severity score against the initial 
score. 
1) C.S. –     Clinically stable, i.e. 
severity score remains as against the 
initial score. 
2) C.I. - 1 – Encouraging   i.e. 1 
degree reduction in the severity score, 
against the initial score. i.e. reduction 
from mild – normal, moderate – mild, 
severe – moderate. 
3) C.I. – 2 – Good    i.e. 2 
degree reduction in the severity score, 
against the initial score. i.e. reduction 
from   moderate – normal, sever – mild. 
4) C.I. – 3 – Excellent   i.e. 3 
degree reduction in the severity score, 
against the initial score. i.e. sever – 
normal. 
 
Grading for the clinical improvement on 
over all severity. 
1) C.D:     Deteriorate (increase in the 
severity score) 
2) C.S:      Stabilized (no change in the 
severity score) 
3) C.I – 1:  Encouraging (1-12 
reduction in the severity score) 
4) C.I – 2:  Good (13-24 reduction in 
the severity score) 
5) C.I – 3:  Excellent (25-36 reduction 
in the severity score) 
 
Data Collection  
Assessment for individual signs and 
symptoms and overall clinical 
improvement was done. The data was 
collected from each group at Before 
treatment, After treatment and After 
follow-up. Scoring was done and finally the 
data was collected, compared and analyzed, 
tabulated as convenient.  
 
Statistical Analysis 
The data collected were statistically 
analyzed with the help of microsoft excel XP 
version under the guidance of statistician. 
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The data was computed for mean standard 
deviation, standard error, ‘t’ value and P 
Values. P value was obtained using 
student’s paired ‘t’ test. Significance of the 
results was based on the P value. The 
statistical values from each group were 
collected and tabulated as convenient or 
compared and analyzed. 
 
 
RESULT RELATED OBSERVATIONS FOR INDIVIDUAL GROUPS: 
CHARTS OF RESPONSE AT THE END OF TREATMENT 
RESPONSE OF THE THERAPIES FOR INDIVIDUAL 
GROUPS  (PERCENTAGE)  AFTER TREAMENT 
Variables Groups CD CS C1-1 C1-2 C1-3 
 A 0% 70% 10% 20% 0% 
Pain B 0% 0% 30% 50% 20% 
 C 0% 0% 10% 60% 30% 
 A 0% 10% 40% 50% 0% 
Bleeding B 0% 0% 50% 40% 10% 
 C 0% 80% 0% 10% 10% 
 A 0% 20% 40% 40% 0% 
Nature of Stool B 0% 90% 10% 0% 0% 
 C 0% 0% 10% 60% 30% 
 A 0% 0% 20% 40% 40% 
Pressure on defecation B 0% 90% 10% 0% 0% 
 C 0% 0% 10% 60% 30% 
 A 0% 0% 30% 60% 10% 
Pruritus ani B 0% 0% 60% 40% 0% 
 C 0% 0% 30% 40% 30% 
 A 0% 0% 20% 70% 10% 
Mucous Discharge B 0% 0% 60% 40% 0% 
 C 0% 0% 30% 40% 30% 
 A 0% 100% 0% 0% 0% 
External B 0% 100% 0% 0% 0% 
 C 0% 100% 0% 0% 0% 
 A 0% 100% 0% 0% 0% 
Internal B 0% 100% 0% 0% 0% 
 C 0% 100% 0% 0% 0% 
 A 0% 30% 30% 40% 0% 
Size B 0% 0% 40% 50% 0% 
 C 0% 0% 0% 60% 40% 
 A 0% 30% 30% 40% 0% 
Character B 0% 10% 40% 50% 0% 
 C 0% 0% 0% 70% 30% 
 A 0% 70% 0% 30% 0% 
Pressure on tenderness B 0% 0% 60% 40% 0% 
 C 0% 0% 50% 50% 0% 
 A 0% 60% 0% 30% 10% 
Movement B 0% 90% 0% 10% 0% 
 C 0% 90% 0% 10% 0% 
 A 0% 0% 100% 0% 0% 
Over all B 0% 0% 100% 0% 0% 
 C 0% 0% 100% 0% 0% 
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CHARTS OF RESPONSE AT THE END OF FOLLOW UP 
RESPONSE OF THE THERAPIES FOR INDIVIDUAL GROUP 
  (PERCENTAGE) AT THE END OF FOLLOW UP   
Variables Groups CD CS C1-1 C1-2 C1-3 
 A 0% 70% 0% 30% 0% 
Pain B 0% 0% 40% 40% 20% 
 C 0% 0% 10% 60% 30% 
 A 0% 10% 40% 50% 0% 
Bleeding B 0% 10% 40% 20% 30% 
 C 0% 80% 0% 10% 10% 
 A 0% 0% 40% 60% 0% 
Nature of Stool B 0% 90% 0% 0% 0% 
 C 0% 0% 10% 60% 30% 
 A 0% 0% 40% 60% 0% 
Pressure on defecation B 0% 70% 10% 20% 0% 
 C 0% 10% 60% 30% 0% 
 A 0% 0% 10% 60% 30% 
Prurituss ani B 0% 0% 60% 40% 0% 
 C 0% 0% 30% 40% 30% 
 A 0% 0% 20% 70% 10% 
Mucous Discharge B 0% 10% 70% 20% 0% 
 C 0% 30% 40% 30% 0% 
 A 0% 100% 0% 0% 0% 
External B 0% 100% 0% 0% 0% 
 C 0% 100% 0% 0% 0% 
 A 0% 100% 0% 0% 0% 
Internal B 0% 100% 0% 0% 0% 
 C 0% 100% 0% 0% 0% 
 A 0% 10% 50% 40% 0% 
Size B 0% 10% 40% 50% 0% 
 C 0% 0% 0% 60% 40% 
 A 0% 30% 30% 40% 0% 
Character B 0% 0% 40% 60% 0% 
 C 0% 0% 0% 70% 30% 
 A 0% 60% 10% 30% 0% 
Pressure on tenderness B 0% 0% 40% 60% 0% 
 C 0% 0% 50% 50% 0% 
 A 0% 60% 0% 30% 10% 
Movement B 0% 90% 0% 10% 0% 
 C 0% 90% 0% 10% 0% 
 A 0% 0% 10% 90% 0% 
Over all B 0% 0% 0% 100% 0% 
 C 0% 0% 0% 100% 0% 
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STATISTICAL ANALYSIS OF GROUP - A    RESULTS 
Variables Grading Mean S.D S.E. t P. Value Significance 
 B.T 1.5 0.8498 0.2687 - - - 
Pain A.T 0.5 0.8498 0.2687 2.63 0.169 NS 
 F.U 0.6 0.966 0.3055 2.21 0.0401 S 
 B.T 3.0 0.6667 0.2108 - - - 
Bleeding A.T 1.4 0.6992 0.2211 5.24 0.0001 HS 
 F.U 1.4 0.6992 0.2211 5.24 0.0001 HS 
 B.T 3.3 0.6749 0.2134 - - - 
Nature of Stool A.T 2.2 0.7888 0.2494 3.35 0.0036 S 
 F.U 1.6 0.5164 0.1633 6.33 0.0000 HS 
 B.T 3.3 0.6749 0.2134 - - - 
Pressure on defecation A.T 2.2 0.7888 0.2494 3.35 0.0036 S 
 F.U 1.6 0.5164 0.1633 6.33 0.0000 HS 
 B.T 3.2 0.6325 0.2 - - - 
Pruritus ani A.T 1.8 0.6325 0.2 4.95 0.0001 HS 
 F.U 2.2 0.6325 0.2 3.54 0.0024 S 
 B.T 3.3 0.4830 0.1528 - - - 
Mucous Discharge A.T 1.9 0.5676 0.1795 5.94 0.0000 HS 
 F.U 1.9 0.5676 0.1795 5.94 0.0000 HS 
 B.T 1.6 1.075 0.33994 - - - 
External A.T 0.0 0.000 0.000 4.7066 0.0001 HS 
 F.U 0.0 0.000 0.000 4.7066 0.0001 HS 
 B.T 1.7 0.9487 0.29810 - - - 
Internal A.T 0.0 0.000 0.000 5.7026 0.0000 HS 
 F.U 0.0 0.000 0.000 5.7026 0.0000 HS 
 B.T 2.5 0.5270 0.1667 - - - 
Size A.T 1.1 0.8756 0.2769 4.33 0.0004 HS 
 F.U 1.3 0.6749 0.2134 4.43 0.0003 HS 
 B.T 2.5 0.5270 0.1667 - - - 
Character A.T 1.1 0.8756 0.2769 4.43 0.0003 HS 
 F.U 1.1 0.8756 0.2769 4.33 0.0004 HS 
 B.T 1.9 1.287 0.4069 - - - 
Pressure on tenderness A.T 0.6 0.966 0.3055 2.55 0.0199 S 
 F.U 0.7 0.9487 0.3 2.37 0.0289 S 
 B.T 2.0 1.333 0.4216 - - - 
Movement A.T 0.9 1.197 0.3786 1.94 0.0681 NS 
 F.U 0.9 1.197 0.3786 1.94 0.0681 NS 
 B.T 29.80 4.517 1.428 - - - 
Over all A.T 16.20 1.549 0.4899 9.01 0.0000 HS 
 F.U 15.80 2.741 0.8667 8.38 0.0000 HS 
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STATISTICAL ANALYSIS OF GROUP - B    RESULTS 
Variables Grading Mean S.D S.E. t P. Value Significance 
 B.T 3.000 0.6667 0.2108 - - - 
Pain A.T 1.900 0.7379 0.2333 3.50 0.0026 S 
 F.U 1.800 0.7888 0.2494 3.67 0.0017 S 
 B.T 2.900 0.5676 0.1759 - - - 
Bleeding A.T 1.600 0.6992 0.2211 4.56 0.0002 HS 
 F.U 1.700 1.059 0.335 3.16 0.0054 S 
 B.T 2.600 0.5164 0.1633 - - - 
Nature of Stool A.T 0.100 0.3162 0.100 13.06 0.0000 HS 
 F.U 0.100 0.3162 0.100 13.06 0.0000 HS 
 B.T 2.800 0.4216 0.133 - - - 
Pressure on defecation A.T 0.100 0.3162 0.100 16.20 0.0000 HS 
 F.U 0.500 0.8492 0.2687 7.67 0.0000 HS 
 B.T 2.500 0.5270 0.1667 - - - 
Pruritus ani A.T 1.400 0.5164 0.1663 4.71 0.0002 HS 
 F.U 1.400 0.5164 0.1663 4.71 0.0002 HS 
 B.T 2.500 0.5270 0.1667 - - - 
Mucous Discharge A.T 1.400 0.5164 0.1663 4.71 0.0002 HS 
 F.U 1.100 0.5676 0.1795 5.72 0.0000 HS 
 B.T 2.3 0.8233 0.2603 - - - 
External A.T 0.0 0.0000 0.0000 8.834 0.0000 HS 
 F.U 0.0 0.0000 0.0000 8.834 0.0000 HS 
 B.T 1.1 0.3162 0.0999 - - - 
Internal A.T 0.0 0.0000 0.0000 11.011 0.0000 HS 
 F.U 0.0 0.0000 0.0000 11.011 0.0000 HS 
 B.T 2.800 0.6325 0.200 - - - 
Size A.T 1.600 0.5164 0.1633 4.65 0.0002 HS 
 F.U 1.600 0.5164 0.1633 4.65 0.0002 HS 
 B.T 2.700 0.6749 0.2134 - - - 
Character A.T 1.400 0.6992 0.2211 4.23 0.0005 HS 
 F.U 1.400 0.6992 0.2211 4.23 0.0005 HS 
 B.T 2.700 0.4830 0.1528 - - - 
Pressure on tenderness A.T 1.400 0.5164 0.1633 5.81 0.0000 HS 
 F.U 1.600 0.5164 0.1633 4.92 0.0001 HS 
 B.T 1.200 0.6325 0.200 - - - 
Movement A.T 0.200 0.6325 0.200 3.54 0.0024 S 
 F.U 0.200 0.6325 0.200 3.54 0.0024 S 
 B.T 29.00 2.055 0.6498 - - - 
Over all A.T 17.90 1.524 0.4819 13.72 0.0000 HS 
 F.U 17.50 1.958 0.6191 12.81 0.0000 HS 
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STATISTICAL ANALYSIS OF GROUP - C   RESULTS 
Variables Grading Mean S.D S.E. t P. Value Significance 
 B.T 3.3 0.4830 0.1528 - - - 
Pain A.T 2.2 0.6325 0.200 4.37 0.0004 HS 
 F.U 2.2 0.6325 0.200 4.37 0.0004 HS 
 B.T 1.5 1.080 0.3416 - - - 
Bleeding A.T 0.5 1.080 0.3416 2.07 0.0531 NS 
 F.U 0.5 1.080 0.3416 2.07 0.0531 NS 
 B.T 3.3 0.483 0.1528 - - - 
Nature of Stool A.T 2.2 0.6325 0.200 4.37 0.0004 HS 
 F.U 2.2 0.6325 0.200 4.37 0.0004 HS 
 B.T 3.3 0.4830 0.1528 - - - 
Pressure on defecation A.T 2.2 0.6325 0.2 4.37 0.0004 HS 
 F.U 2.2 0.6325 0.2 4.37 0.0004 HS 
 B.T 3.1 0.7379 0.233 - - - 
Pruritus ani A.T 2.0 0.8165 0.2582 3.16 0.0054 S 
 F.U 2.0 0.8165 0.2582 3.16 0.0054 S 
 B.T 3.1 0.7379 0.2333 - - - 
Mucous Discharge A.T 2.0 0.8165 0.2582 3.16 0.0054 S 
 F.U 2.0 0.8165 0.2582 3.16 0.0054 S 
 B.T 2.4 0.8433 0.26667 - - - 
External A.T 0.0 0.0000 0.000 8.9997 0.0000 HS 
 F.U 0.0 0.0000 0.000 8.9997 0.0000 HS 
 B.T 1.1 0.3162 0.09999 - - - 
Internal A.T 0.0 0.0000 0.0000 11.010 0.0000 HS 
 F.U 0.0 0.0000 0.0000 11.010 0.0000 HS 
 B.T 3.5 0.5270 0.1667 - - - 
Size A.T 2.4 0.5164 0.1633 4.71 0.0002 HS 
 F.U 2.4 0.5164 0.1633 4.71 0.0002 HS 
 B.T 3.5 0.5270 0.1667 - - - 
Character A.T 2.3 0.4830 0.1528 5.31 0.0000 HS 
 F.U 2.3 0.4830 0.1528 5.31 0.0000 HS 
 B.T 2.6 0.5164 0.1633 - - - 
Pressure on tenderness A.T 1.5 0.5270 0.1667 4.71 0.0002 HS 
 F.U 1.5 0.5270 0.1667 4.71 0.0002 HS 
 B.T 1.2 0.6325 0.2 - - - 
Movement A.T 0.2 0.6325 0.2 3.54 0.0024 S 
 F.U 0.2 0.6325 0.2 3.54 0.0024 S 
 B.T 31.90 2.132 0.6741 - - - 
Over all A.T 14.40 1.075 0.3399 23.18 0.0000 HS 
 F.U 14.40 1.075 0.3399 23.18 0.0000 HS 
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Disscussion 
On title 
However modern science as 
advanced and reached highest goal in 
medical aspects. It is yet to come up with 
complete treatment plan for arsha as 
surgical procedures find unjudicial 
application. The present study tittled “The 
Medical Management of Arsha with 
chirabilwadi quatha and kaseesadi thaila 
sthanika abhyanga” is a sincere attempt for 
the management of arsha which could be 
practicable at O.P.D. levels too. 
 
Probable mode of action 
 
Chirabilwadi quatha 
Here, due to nidanakara factors 
apanavata gets aggravated that afflicts the 
anal sphincter leads to arsha. The 
ingredients of chirabilwadi quatha is 
having vata shamana properties. So it 
decreases the aggravated apanavata and 
prevents the affliction to anal sphincters 
and cures the arsha. 
 
Kaseesadi Taila 
It acts on haemorrhoids in two 
ways: 
1. It cauterises the pile mass directly 
because of its ksharana guna 
(corrosive nature) and makes 
ropana (healing) of the same. 
2. It coagulates protein in 
haemorrhoidal plexus. 
The coagulation of protein leads to 
disintegration of haemoglobin into haem 
and globin. Synergy of these action result in 
decreasing the size of the pile mass. 
Further, necrosis of the tissue in the 
haemorrhoidal vein will occur. The 
necrosed tissue slough out as blackish 
brown. The haem present in the slough 
gives the discharge its colour. The tissue 
becomes fibrosed and scar formation seen. 
The haemorrhoidal vein obliterates 
permanently and there is no recurrence of 
haemorrhoids. 
 
On Results 
All three groups had shown high 
significant at the end of treatment and all 
three groups were withheld to end of 
treatment and end of follow up. 
 
Conclusions 
1) Majority chirabilwadi quatha relieves 
the subjective criteria variables and 
kaseesadi thaila relieves the objective 
criteria variables.  
2) Observed that reduction of varicosed 
haemorroidal veins. 
3) All the groups showed highly 
significant after treatment and after 
follow up as compared to before 
treatment (on the basis of P value). 
Whereas group C shows high 
significant difference as compare with 
group A and group B. (on the basis of 
‘t’ value).   
4)  In the overall clinical study effective 
medical management is possible but 
not complete cure. 
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